During the past decade, Clinique Sourdille conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Clinique Sourdille" are "Idiopathic Epimacular Membrane" (1 trials), "Low-grade Serous Fallopian Tube Cancer" (1 trials), "Low-grade Serous Ovarian Cancer" (1 trials) and "Low-grade Serous Peritoneal Cancer" (1 trials). Many other conditions were trialed in "Clinique Sourdille" in a lesser frequency.

Most popular intervention types in "Clinique Sourdille" are "Drug" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "ILM Peeling" (1 trials), "MEK162, MEK inhibitor; oral" (1 trials) and "Physician's choice chemotherapy" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique Sourdille" are 1 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique Sourdille". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Clinique Sourdille, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Clinique Sourdille, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".